PET-CT在胃肠道间质瘤中的应用

冼伟均; 冯彦林; 冼伟均; 冯彦林

doi:10.3760/cma.j.issn.1673-4114.2009.03.004

[1]

林苏,刘懿.胃肠道间质瘤.国外医学·消化系疾病分册,2005,25(1):25-28.

[2]

Miettinen M. Sobin LH, Lasota J. Gastrointestinal stromal tumors of the stomach:a clinicopathologic, immunohistochemical, and molecular genetic study of 1765 cases with long-term follow-up. Am J Surg Pathol, 2005, 29(1):52-68.

[3]

邓伟雄,庄思敏,温东东,等.恶性胃肠道间质瘤25例诊治体会.广东医学,2004,25(4):432-433.

[4]

Mazur MI, Clark HB. Gastric stromal tumors. Reappraisal of histogenesis. Am J Surg Pathol, 1983, 7(6):507-519.

[5]

Miettinen M, Lasota J. Gastrointestinal stromal tumors-deftnition, clinical, histological, immunohistochemical, and molecular genetic features and diferential diagnosis. Virchows Arch, 2001, 438(1):1-12.

[6]

Corless CL, Fletcher JA, Heinrich MC. Biology of gastrointestinal stromal tumors. J Clin Oncol, 2004, 22(18):3813-3825.

[7]

Mignon F, Julié C, Izzillo R, et al. Imaging features of gastric stromal tumors:radiologic-pathologic correlation. Report of 4 cases. J Radiol, 2000, 81(8):874-881.

[8]

王冬青,曾蒙苏,饶圣祥,等.CT在胃肠道间质瘤诊断及随访中的价值.实用放射学杂志,2006,22(6):695-697.

[9]

Ji F,Wang ZW, Wang LJ, et al. Clinicopathological characteristics of gastrointestinal mesenchymal tumors and diagnostic value of endoscopic uhrasonography. J Gastroenterol Hepatol, 2008, 23(8pt z):e318-e324.

[10]

宋建兵,汤继军,郭应兴,等.影像学检查对胃肠道间质瘤诊断价值的临床分析.实用放射学杂志,2006,22(7):832-834.

[11]

Kamiyama Y, Aihara R, Nakabayashi T, et al. ¹⁸F-fluorodeoxyglucose positron emission tomography:useful technique for predicting malignant potential of gastrointestinal stromal tumors. World J Surg, 2005, 29(11):1429-1435.

[12]

Steigen SE, Bjerkehagen B, Haugland HK, et al. Diagnostic and prognostic markers for gastrointestinal stromal tumors in Norway. Mod Pathol, 2008, 21(1):46-53.

[13]

Wong NA, Young R, Malcomson RD, et al. Prognostic indicators for gastrointestinal stromal tumors:a clinicopathological and immunohistochemical study of 108 resected cases of the stomach.Histopathology, 2003, 43(2):118-126.

[14]

周立群,陈剑秋.胃肠道间质瘤的诊治研究进展.医学综述,2008,14(11):1467-1468.

[15]

万德森,伍小军,梁小曼,等.胃肠道间质瘤的外科治疗.中华胃肠外科杂志,2003,6(5):288-291.

[16]

Demetri GD, van Mehren M, Blanke CD, et al. Efficacy and safety of imatinib mesylate in advanced gastrointestinal stromal tumors. N Engl J Med, 2002, 347(7):472-480.

[17]

Nishida T, Shirao K, Sawaki A, et al. Efficacy and safety profile of imatinib mesylate (ST1571) in Japanese patients with advaneed gastrointestinal stromal tumors:a phase II study(ST1871B1202). Int J Clin Oncol, 2008, 13(3):244-251.

[18]

Antoch G, Kanja J, Bauer S, et al. Comparison of PET, CT, and dual-modality PET/CT imaging for monitoring of imatinib (STI571) therapy in patients with gastrointestinal stromal tumors. J Nucl Med, 2004, 45(3):357-365.

[19]

Goerres GW, Stupp R, Barghouth G, et al. The value of PET, CT and in-line PET/CT in patients with gastrointestinal stromal tumours:long-term outcome of treatment with imatinib mesylate. Eur J Nucl Med Mol Imaging, 2005, 32(2):153-162.

[20]

张孝平,管建国.甲磺酸伊马替尼在胃肠道间质瘤中的应用.基础医学论坛,2007,11(9):456-457.

[21]

Trent JC, Ramdas L, Dupart J, et al. Early effects of imatinib mesylate on the expression of insulin-like growth factor binding protein-3 and positron emission tomography in patients with gastrointestinal stromal tumor. Cancer, 2006, 107(8):1898-1908.

[22]

Stroobants S, Goeminne J, Seegers M, et al. ¹⁸FDG-positron emission tomography for the early prediction of response in advanced soft tissue sarcoma treated with imatinib mesylate (Glivec). Eur J Cancer, 2003, 39(14):2012-2020.

[23]

Heinicke T, Wardelmann E, Sauerbnlch T, et al. Very early detection of response to imatinib mesylate therapy of gastrointestinal stromal tumors using ¹⁸fluoro-deoxyglucose-positron emission tomography. Anticancer Res, 2005, 25(6C):4591-4594.

[24]

万德森.胃肠道间质瘤术后复发转移的治疗.肿瘤研究与临床,2006,18(8):524-526.

[25]

DeMatteo RP, Lewis JJ, Leung D, et al. Two hundred gastrointestinal stromal tumors:recurrence patterns and prognostic factors for survival. Ann Surg, 2000, 231(1):51-58.

[26]

Sobhani I, Tiret E, Lebtahi R, et al. Early detection of recurrence by ¹⁸FDG-PET in the follow-up of patients with colorectal cancer. Br J Cancer, 2008, 98(5):875-880.